Rxcurve
HCPCS J1580 · per 80 MG

Garamycin gentamicin inj

Products billed under this code include Gentamicin Sulfate.

Payment limit per 80 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J1580

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Gentamicin Sulfate Hikma Pharmaceuticals USA Inc. 00143-9128-25 25 $46.225
Gentamicin Sulfate Baxter Healthcare Corporation 00338-0503-48 1 $1.849
Gentamicin Sulfate Baxter Healthcare Corporation 00338-0505-48 2 $3.698
Gentamicin Sulfate Baxter Healthcare Corporation 00338-0507-41 1 $1.849
Gentamicin Sulfate Baxter Healthcare Corporation 00338-0507-48 2 $3.698
Gentamicin Sulfate Baxter Healthcare Corporation 00338-0509-41 1 $1.849
Gentamicin Sulfate Baxter Healthcare Corporation 00338-0511-41 2 $3.698
Gentamicin Sulfate Henry Schein Inc. 00404-9865-02 1 $1.849
Gentamicin Sulfate Henry Schein Inc. 00404-9866-20 10 $18.49
Gentamicin Sulfate Pfizer Inc 00409-1207-03 25 $46.225
Show all 21 products
ProductLabelerNDCUnits / pkgLimit / pkg
Gentamicin Sulfate HF Acquisition Co. LLC, DBA HealthFirst 51662-1508-03 250 $462.25
Gentamicin Sulfate HF Acquisition Co. LLC, DBA HealthFirst 51662-1597-03 25 $46.225
Gentamicin Sulfate Eugia US LLC 55150-0401-25 25 $46.225
Gentamicin Sulfate Eugia US LLC 55150-0402-25 25 $46.225
Gentamicin Sulfate Eugia US LLC 55150-0403-25 250 $462.25
Gentamicin Sulfate FreseniUS Kabi USA, LLC 63323-0010-02 25 $46.225
Gentamicin Sulfate FreseniUS Kabi USA, LLC 63323-0010-20 250 $462.25
Gentamicin Sulfate FreseniUS Kabi USA, LLC 63323-0010-94 25 $46.225
Gentamicin Sulfate FreseniUS Kabi USA, LLC 63323-0010-95 250 $462.25
Gentamicin Sulfate FreseniUS Kabi USA, LLC 63323-0173-02 25 $46.225
Gentamicin Sulfate FreseniUS Kabi USA, LLC 63323-0173-94 25 $46.225

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $1.849 −$0.076 80 MG Garamycin gentamicin inj v1, posted September 17, 2026
3Q26 $1.925 −$0.003 80 MG Garamycin gentamicin inj v1, posted September 15, 2026
2Q26 $1.928 −$0.238 80 MG Garamycin gentamicin inj v1, posted September 15, 2026
1Q26 $2.166 −$0.042 80 MG Garamycin gentamicin inj v1, posted September 15, 2026
4Q25 $2.208 −$0.407 80 MG Garamycin gentamicin inj v1, posted September 8, 2026
3Q25 $2.615 +$0.148 80 MG Garamycin gentamicin inj v1, posted March 10, 2026
2Q25 $2.467 −$0.003 80 MG Garamycin gentamicin inj v1, posted March 10, 2026
1Q25 $2.47 −$0.27 80 MG Garamycin gentamicin inj v1, posted December 19, 2025
4Q24 $2.74 +$0.674 80 MG Garamycin gentamicin inj v1, posted June 11, 2025
3Q24 $2.066 −$0.667 80 MG Garamycin gentamicin inj v1, posted June 11, 2025
2Q24 $2.733 +$0.048 80 MG Garamycin gentamicin inj v1, posted March 11, 2025
1Q24 $2.685 −$0.237 80 MG Garamycin gentamicin inj v1, posted December 19, 2024
4Q23 $2.922 −$0.07 80 MG Garamycin gentamicin inj v1, posted October 10, 2024
3Q23 $2.992 +$0.455 80 MG Garamycin gentamicin inj v1, posted June 5, 2024
2Q23 $2.537 −$0.257 80 MG Garamycin gentamicin inj v1, posted February 23, 2024
1Q23 $2.794 +$0.132 80 MG Garamycin gentamicin inj v1, posted December 6, 2023
4Q22 $2.662 +$0.297 80 MG Garamycin gentamicin inj v1, posted June 22, 2023
3Q22 $2.365 +$0.802 80 MG Garamycin gentamicin inj v1, posted June 9, 2023
2Q22 $1.563 +$0.15 80 MG Garamycin gentamicin inj v1, posted December 14, 2022
1Q22 $1.413 −$0.262 80 MG Garamycin gentamicin inj v1, posted June 8, 2022
4Q21 $1.675 −$0.211 80 MG Garamycin gentamicin inj v1, posted June 2, 2022
3Q21 $1.886 −$0.06 80 MG Garamycin gentamicin inj v1, posted June 2, 2022
2Q21 $1.946 +$0.168 80 MG Garamycin gentamicin inj v1, posted March 1, 2022
1Q21 $1.778 – 80 MG Garamycin gentamicin inj v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files